HNRNPA2B1 and breast carcinoma: In this study, people analyzed the inhibitory effect of knockdown of hnRNPA2/B1 on the invasion and proliferation of breast cancer cells through PI3K/AKT signaling and provided a laboratory basis for targeted therapy of clinical patients.